ampelopsin has been researched along with Parkinson Disease in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 4 (57.14) | 2.80 |
| Authors | Studies |
|---|---|
| Decossas-Mendoza, M; Krisa, S; Lambert, O; Mérillon, JM; Richard, T; Temsamani, H | 1 |
| Copeland, RL; Csoka, AB; Getachew, B; Manaye, KF; Tizabi, Y | 1 |
| Chen, N; Feng, SD; Li, MW; Li, Q; Ling, HY; Luo, JD; Wang, ZH; Wu, HL | 1 |
| Kou, X; Niu, M; Tong, S; Zhang, M; Zhang, Y; Zhu, Y | 1 |
| Cao, T; Guo, CH; Waddington, JL; Zhen, XC; Zheng, LT | 1 |
| Chen, B; Cui, W; Jia, L; Liu, F; Lu, F; Sang, J; Wang, Y; Wei, W; Zhao, W | 1 |
| Cao, T; Ren, ZX; Zhao, YF; Zhen, XC | 1 |
7 other study(ies) available for ampelopsin and Parkinson Disease
| Article | Year |
|---|---|
Piceatannol and Other Wine Stilbenes: A Pool of Inhibitors against α-Synuclein Aggregation and Cytotoxicity.
Topics: alpha-Synuclein; Animals; Benzothiazoles; Cell Survival; Electrophoresis, Polyacrylamide Gel; Flavonoids; Microscopy, Electron, Transmission; Parkinson Disease; PC12 Cells; Phenols; Rats; Stilbenes; Thiazoles; Wine | 2016 |
Dihydromyricetin Protects Against Salsolinol-Induced Toxicity in Dopaminergic Cell Line: Implication for Parkinson's Disease.
Topics: Cell Line, Tumor; Dopamine; Dopaminergic Neurons; gamma-Aminobutyric Acid; Humans; Neuroblastoma; Neurodegenerative Diseases; Neuroprotective Agents; Parkinson Disease | 2023 |
[Dihydromyricetin improves Parkinson's disease-like lesions in T2DM rats by activating AMPK/ULK1 pathway].
Topics: AMP-Activated Protein Kinases; Animals; Autophagy-Related Protein-1 Homolog; Diabetes Mellitus, Type 2; Parkinson Disease; Rats; Rats, Sprague-Dawley | 2023 |
[Dihydromyricetin alleviates pyroptosis and necroptosis in mice with MPTP-induced chronic Parkinson's disease by inducing autophagy].
Topics: Animals; Autophagy; Interleukin-6; Mice; Mice, Inbred C57BL; Necroptosis; Neuroinflammatory Diseases; NLR Family, Pyrin Domain-Containing 3 Protein; Parkinson Disease; Probenecid; Pyroptosis; Tumor Necrosis Factor-alpha | 2023 |
Development and characterization of an inducible Dicer conditional knockout mouse model of Parkinson's disease: validation of the antiparkinsonian effects of a sigma-1 receptor agonist and dihydromyricetin.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Antiparkinson Agents; DEAD-box RNA Helicases; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Flavonols; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Morpholines; Oxidopamine; Parkinson Disease; Receptors, sigma; Ribonuclease III; Sigma-1 Receptor; Tamoxifen | 2020 |
Dihydromyricetin Inhibits α-Synuclein Aggregation, Disrupts Preformed Fibrils, and Protects Neuronal Cells in Culture against Amyloid-Induced Cytotoxicity.
Topics: alpha-Synuclein; Ampelopsis; Amyloid beta-Peptides; Animals; Apoptosis; Drugs, Chinese Herbal; Flavonols; Humans; Hydrophobic and Hydrophilic Interactions; Neurons; Neuroprotective Agents; Parkinson Disease; PC12 Cells; Protein Aggregates; Rats | 2019 |
Dihydromyricetin protects neurons in an MPTP-induced model of Parkinson's disease by suppressing glycogen synthase kinase-3 beta activity.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Cell Line; Flavonols; Glycogen Synthase Kinase 3 beta; Male; Mice, Inbred C57BL; Neuroprotective Agents; Parkinson Disease; Protein Kinase Inhibitors; Rats | 2016 |